We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CELU market cap is 69.48M. The company's latest EPS is USD -8.9287 and P/E is -1.14.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.13M | 3.94M | 2.94M | 3.79M | 12.11M |
| Operating Income | -35.35M | -82.8M | -127.88M | -99.26M | -10.85M |
| Net Income | 24.43M | -64.02M | -47.95M | -93.88M | 9.55M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 21.34M | 17.98M | 22.77M |
| Operating Income | -564k | -4.22M | -150.2M | -151.88M | -296.63M |
| Net Income | 2.51M | -2.63M | -100.12M | 14.19M | -196.3M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 401.07M | 362.42M | 246.42M | 157.19M | 143.89M |
| Total Liabilities | 202.17M | 206.79M | 127.92M | 126.95M | 102.93M |
| Total Equity | 198.9M | 155.63M | 118.5M | 30.25M | 40.96M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 291.61M | 292.16M | 414.13M | 401.07M | 143.89M |
| Total Liabilities | 11.04M | 14.22M | 314.71M | 202.17M | 102.93M |
| Total Equity | 5M | 5M | 99.42M | 198.9M | 40.96M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -137.88M | -15M | -26.02M | -34.34M | -38.69M |
| Investing | -5.24M | -3.21M | -3.24M | -3.47M | -4.05M |
| Financing | 119.84M | 12.76M | 18.37M | 24.11M | 24.09M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -1.1M | -1.18M | -110.1M | -137.88M | -38.69M |
| Investing | -286.85M | 579k | -5.9M | -5.24M | -4.05M |
| Financing | 288.84M | N/A | 98.56M | 119.84M | 24.09M |
| Market Cap | 69.48M |
| Price to Earnings Ratio | -1.14 |
| Price to Sales Ratio | 9.85 |
| Price to Cash Ratio | 990.29 |
| Price to Book Ratio | 5.47 |
| Dividend Yield | - |
| Shares Outstanding | 21.98M |
| Average Volume (1 week) | 11.21k |
| Average Volume (1 Month) | 9.56k |
| 52 Week Change | 6.77% |
| 52 Week High | 7.97 |
| 52 Week Low | 1.59 |
| Spread (Intraday) | 2.8 (77.78%) |
| Company Name | Celularity Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.celularity.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
